Opinion

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

July, 2025

Opinion

We should never stop our efforts to provide the right patient with the right medicine at the right time

Photo from Matthijs Van Meerveld/Twitter

Jun 14, 2023, 12:42

We should never stop our efforts to provide the right patient with the right medicine at the right time

According to Matthijs Van Meerveld, “The right medicine for the right patient at the right time is a notion all stakeholders easily subscribe to, but it is far from easy to achieve this in practice. At Menarini Stemline our rapidly growing team of decidated pharma professionals is committed to addressing unmet needs in hematology with our medicines for the treatment of multiple myeloma and the rare disease Blastic plasmacytoid dendritic cell neoplasm (BPDCN). The EHA congress in Frankfurt provided an excellent opportunity to enhance our understanding of the optimal treatment of people living with these diseases, and to forge collaborations on advancing access to treatment. The ever evolving science is breathtaking, and we should never stop our efforts to provide the right patient with the right medicine at the right time”.

Source:

BPDCN Hematology Matthijs Van Meerveld Menarini Stemline

'

25 Posts Not To Miss From ESMO GI 2025

'

Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update

'

Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career

'

Vivek Subbiah: It’s Time We Evolve WHO Cancer Classification

'

ESMO 50th Anniversary: Half a Century of Evidence-Based Cancer Care

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Drugs

Jul 10, 2025, 01:19

Cisplatin in Cancer Treatment: Mechanism, Resistance, Toxicity, and Future Directions

Blog

Jul 9, 2025, 23:49

Sami Mansfield: Jumpstart July - Education plus Empowerment for Menopause After Cancer

Insight

Jul 9, 2025, 23:06

Steven Rosenberg: The beginning of a new way to use immunotherapy

Blog

Jul 9, 2025, 21:20

Herbert Loong: Sarcomas Are a Group of Rare Diseases Which Benefits From Awareness and Specialist Care

Blog

Jul 9, 2025, 21:13

Asfand Yar Cheema: Calling All Internal Medicine Residents

Opinion

Jul 9, 2025, 21:08

Paolo Tarantino Opens the 3rd Annual ADC Toxicity Summit

Insight

Jul 9, 2025, 21:02

Marianna Vitaloni: I'm Incredibly Grateful to the Patients Who Shared Their Stories With Us

Blog

Jul 9, 2025, 20:28

Jennifer Guida: I Had the Privilege to Lead Pioneering Work at the NCI Focused on Cancer Survivorship, Healthy Aging, and Resilience

Blog

Jul 9, 2025, 20:27

Upcoming Global Cancer Research and Control Seminar Series - NCI Center for Global Health

Blog

Jul 9, 2025, 20:16

Rob Winn: Join for the Closing the Gap Cancer Summit

Blog

Jul 9, 2025, 20:10

Every Person Living with NCDs Such as Cancer Has Access to the Treatment and Care They Need - UICC

Blog

Jul 9, 2025, 20:00

Join the global myeloma community at IMS25 - International Myeloma Society